Abstract
The aim of this study was to review the quality of the diagnostic work-up for acute encephalitis carried out at our center in a cohort of patients with hematological disorders. Our data showed substantial heterogeneity in investigating patients. Not all patients had their CSF tested for viruses commonly responsible for encephalitis in immunocompetent individuals (e.g., VZV, enterovirus). A blood sample for the calculation of the CSF/blood replication ratio was collected in 74% of cases. CSF cultures and immunophenotyping of CSF cells were performed in 77% and 21% of patients, respectively. A multidisciplinary consensus is needed to improve current guidelines and standardize diagnostic protocols.
References
Antonini G, Ceschin V, Morino S, Fiorelli M, Gragnani F, Mengarelli A, Iori AP, Arcese W (1998) Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study. Neurology 50(5):1441–1445
Azik F, Yazal Erdem A, Tavil B, Bayram C, Tunç B, Uçkan D (2014) Neurological complications after allogeneic hematopoietic stem cell transplantation in children, a single center experience. Pediatr Transplant 18(4):405–411
Clark DA (2016) Clinical and laboratory features of human herpesvirus 6 chromosomal integration. Clin Microbiol Infect 22(4):333–339
Colombo AA, Marchioni E, Diamanti L, Di Matteo AM, Baldanti F, Furione M, Cazzola M, Ferretti VV, Pascutto C, Alessandrino EP (2017) Neurological complications involving the central nervous system after allogeneic hematopoietic stem cell transplantation during a period of evolution in transplant modalities: a cohort analysis. Transplantation 101(3):616–623
Diamanti L, Franciotta D, Berzero G, Bini P, Farina LM, Colombo AA, Ceroni M, Marchioni E (2015) Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient with AML. Bone Marrow Transplant 50(8):1125–1126
Dowling MR, Li S, Dey BR, McAfee SL, Hock HR, Spitzer TR, Chen YB, Ballen KK (2018) Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact. Bone Marrow Transplant 53(2):199–206
Guerrero A, Pérez-Simón JA, Gutierrez N, Caballero D, Ortin F, Gomez-Sanchez JC, Cacho J, San Miguel JF (1999) Neurological complications after autologous stem cell transplantation. Eur Neurol 41(1):48–50
Kang JM, Kim YJ, Kim JY, Cho EJ, Lee JH, Lee MH, Lee SH, Sung KW, Koo HH, Yoo KH (2015) Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors. Biol Blood Marrow Transplant 21(6):1091–1098
Maffini E, Festuccia M, Brunello L, Boccadoro M, Giaccone L, Bruno B (2017) Neurologic complications after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 23(3):388–397
Pruitt AA (2018) Central nervous system infections complicating immunosuppression and transplantation. Continuum (Minneap Minn) 24(5, Neuroinfectious Disease):1370–1396
Pruitt AA, Graus F, Rosenfeld MR (2013) Neurological complications of transplantation: part I: hematopoietic cell transplantation. Neurohospitalist 3(1):24–38
Saylor D, Thakur K, Venkatesan A (2015) Acute encephalitis in the immunocompromised individual. Curr Opin Infect Dis 28(4):330–336
Schmidt-Hieber M, Silling G, Schalk E, Heinz W, Panse J, Penack O, Christopeit M, Buchheidt D, Meyding-Lamadé U, Hähnel S, Wolf HH, Ruhnke M, Schwartz S, Maschmeyer G (2016) CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation) Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 27(7):1207–1225
Siegal D, Keller A, Xu W, Bhuta S, Kim DH, Kuruvilla J, Lipton JH, Messner H, Gupta V (2007) Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant 13(11):1369–1379
Solomon T, Michael BD, Smith PE, Sanderson F, Davies NW, Hart IJ, Holland M, Easton A, Buckley C, Kneen R, Beeching NJ, National Encephalitis Guidelines Development and Stakeholder Groups (2012) Management of suspected viral encephalitis in adults - association of British Neurologists and British Infection Association National Guidelines. J Inf Secur 64(4):347–373
Sonneville R, Magalhaes E, Meyfroidt G (2017) Central nervous system infections in immunocompromised patients. Curr Opin Crit Care 23(2):128–133
Stahl JP, Azouvi P, Bruneel F, De Broucker T, Duval X, Fantin B, Girard N, Herrmann JL, Honnorat J, Lecuit M, Mailles A, Martinez-Almoyna L, Morand P, Piroth L, Tattevin P, reviewing group (2017) Guidelines on the management of infectious encephalitis in adults. Med Mal Infect 47(3):179–194
Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL, Hartman BJ, Kaplan SL, Scheld WM, Whitley RJ, Infectious Diseases Society of America (2008) The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 47(3):303–327
Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar J, Bitnun A, Stahl JP, Mailles A, Drebot M, Rupprecht CE, Yoder J, Cope JR, Wilson MR, Whitley RJ, Sullivan J, Granerod J, Jones C, Eastwood K, Ward KN, Durrheim DN, Solbrig MV, Guo-Dong L, Glaser CA, International Encephalitis Consortium (2013) Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the International Encephalitis Consortium. Clin Infect Dis 57(8):1114–1128
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Supplementary Table 1
(DOCX 21 kb)
Rights and permissions
About this article
Cite this article
Vegezzi, E., Berzero, G., Barbetta, D. et al. Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls. J. Neurovirol. 26, 257–263 (2020). https://doi.org/10.1007/s13365-019-00817-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-019-00817-z